Domov › Ulcerózna kolitída › Texas › Houston
Klinické štúdie Ulcerózna kolitída v meste Houston, TX
17 štúdií pre Ulcerózna kolitída hľadá účastníkov v zariadeniach v meste Houston a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Prebieha náborFáza 2
- Integrity Advanced Therapeutics /ID# 283871, Houston
- Novel Research - Bellaire /ID# 280925, Bellaire · 7 míľ odtiaľ
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Prebieha náborFáza 4
- Kelsey Research Foundation, Houston
- MedCare Pharma LLC, Houston
- Spring Clinical Research, Houston
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Prebieha náborFáza 2
- Baylor College of Medicine, Houston
- Intergrity Research, Houston
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Prebieha náborFáza 1/2Vítaní zdravých dobrovoľníkov
- Xencor Investigative Site, Houston
- Xencor Investigative Site, Houston
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Prebieha náborFáza 2
- Site US-030, Houston
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Prebieha náborFáza 3
- Victorium Clinical Research, Houston
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Prebieha náborFáza 2/3
- Texas Children's Hospital, Houston
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Prebieha náborFáza 1
- UT MD Anderson Cancer Center, Houston
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Prebieha náborFáza 2
- Integrity Advanced Therapeutics, Houston
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Prebieha náborFáza 4
- The University of Texas Health Science Center at Houston, Houston
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
Prebieha náborObservačná štúdia
- BAMC, Houston
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Prebieha náborFáza 2
- Baylor College of Medicine, Houston
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Prebieha nábor
- Baylor College of Medicine, Houston
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Prebieha náborObservačná štúdia
- Houston Endoscopy & Research Center, Houston
- BI Research Center, Houston
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Prebieha náborObservačná štúdia
- M D Anderson Cancer Center, Houston
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Prebieha náborFáza 3
- Texas Children's Hospital - Baylor - PIN, Houston
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Prebieha náborFáza 2
- Mirador Therapeutics Selected Site, Houston
Štúdie Ulcerózna kolitída v iných mestách
- New York City, NY23 štúdií
- Orlando, FL22 štúdií
- Miami, FL21 štúdií
- San Antonio, TX16 štúdií
- Tacoma, WA15 štúdií
- Chicago, IL15 štúdií
- San Diego, CA15 štúdií
- Tyler, TX14 štúdií
- Colorado Springs, CO14 štúdií
- Los Angeles, CA13 štúdií
- St. Louis, MO13 štúdií
- Washington, DC12 štúdií
Iné štúdie v Houston
- Nemalobunkový karcinóm pľúc145 štúdií
- Rakovina prsníka126 štúdií
- Rakovina (všetky typy)121 štúdií
- Metastatická rakovina104 štúdií
- Kolorektálny karcinóm102 štúdií
- Rakovina vaječníkov89 štúdií
- Akútna myeloidná leukémia85 štúdií
- Rakovina pľúc78 štúdií
- Rakovina prostaty76 štúdií
- Rakovina endometria68 štúdií
- Rakovina pankreasu61 štúdií
- Melanóm59 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.